Significant effect of age on docetaxel pharmacokinetics in Japanese female breast cancer patients by using the population modeling approach

被引：0
|
作者：
Haruka Onoue
Ikuko Yano
Atsuko Tanaka
Kotaro Itohara
Akiko Hanai
Hiroshi Ishiguro
Hideyuki Motohashi
Satohiro Masuda
Kazuo Matsubara
机构：
[1] Kyoto University,Department of Clinical Pharmacy and Education, Graduate School of Pharmaceutical Sciences
[2] Kyoto University Hospital,Department of Clinical Pharmacology and Therapeutics
[3] Kyoto University,Departmant of Human Sciences, Graduate School of Medicine
[4] Kyoto University,Department of Target Therapy Oncology, Graduate School of Medicine
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Docetaxel; Breast cancer; Population pharmacokinetics; Female hormone; Pharmacogenetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：703 / 710
页数：7
相关论文
共 50 条
  • [1] Significant effect of age on docetaxel pharmacokinetics in Japanese female breast cancer patients by using the population modeling approach
    Onoue, Haruka
    Yano, Ikuko
    Tanaka, Atsuko
    Itohara, Kotaro
    Hanai, Akiko
    Ishiguro, Hiroshi
    Motohashi, Hideyuki
    Masuda, Satohiro
    Matsubara, Kazuo
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (06) : 703 - 710
  • [2] Effect of turmeric supplementation on the pharmacokinetics of paclitaxel in breast cancer patients: A study with population pharmacokinetics approach
    Kalluru, Hindu
    Mallayasamy, Surulivel Rajan
    Kondaveeti, Satish Srinivas
    Chandrasekhar, Vinodhini
    Kalachaveedu, Mangathayaru
    [J]. PHYTOTHERAPY RESEARCH, 2022, 36 (04) : 1761 - 1769
  • [3] Population pharmacokinetics of weekly docetaxel in patients with advanced cancer
    Slaviero, KA
    Clarke, SJ
    McLachlan, AJ
    Blair, EYL
    Rivory, LP
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (01) : 44 - 53
  • [4] Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients
    Peter Nygren
    Kenneth Hande
    Kevin J. Petty
    Margaret Fedgchin
    Kristien van Dyck
    Anup Majumdar
    Debbie Panebianco
    Marina de Smet
    Tuli Ahmed
    M. Gail Murphy
    Keith M. Gottesdiener
    Veronique Cocquyt
    Simon van Belle
    [J]. Cancer Chemotherapy and Pharmacology, 2005, 55 : 609 - 616
  • [5] Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer
    Uday B. Dandamudi
    Laurel M. Adams
    Brendan Johnson
    John Bauman
    Shannon Morris
    Sharon Murray
    R. Timothy Webb
    Elaina Gartner
    Raymond Hohl
    Lionel D. Lewis
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 783 - 790
  • [6] Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer
    Dandamudi, Uday B.
    Adams, Laurel M.
    Johnson, Brendan
    Bauman, John
    Morris, Shannon
    Murray, Sharon
    Webb, R. Timothy
    Gartner, Elaina
    Hohl, Raymond
    Lewis, Lionel D.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 783 - 790
  • [7] Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients
    Nygren, P
    Hande, K
    Petty, KJ
    Fedgchin, M
    van Dyck, K
    Majumdar, A
    Panebianco, D
    de Smet, M
    Ahmed, T
    Murphy, MG
    Gottesdiener, KM
    Cocquyt, V
    van Belle, S
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (06) : 609 - 616
  • [8] Population pharmacokinetics and Toxicities of gemcitabine in Japanese cancer patients
    Kaniwa, N.
    Sugiyama, E.
    Kim, S. R.
    Saito, Y.
    Hasegawa, R.
    Ueno, H.
    Okusaka, T.
    Furuse, J.
    Ishii, H.
    Yoshida, T.
    Saijo, N.
    Sawada, J.
    [J]. PROCEEDINGS OF THE 8TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, : 193 - +
  • [9] Population Pharmacokinetics of Pegasparaginase in pediatric ALL patients: Age as a significant covariate
    Krishnamurthy, Manjunath Nookala
    Patil, Anand
    Narula, Gaurav
    Banavali, Shripad Dinanath
    Gota, Vikram
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 224 - 226
  • [10] Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer
    Bruno, R
    Hille, D
    Riva, A
    Vivier, N
    Huinnink, WWTB
    van Oosterom, AT
    Kaye, SB
    Verweij, J
    Fossella, FV
    Valero, V
    Rigas, JR
    Seidman, AD
    Chevallier, B
    Fumoleau, P
    Burris, HA
    Ravclin, PM
    Sheiner, LB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 187 - 196
12345